Consolidated Guidelines

In this section, we consider the monitoring and evaluation required to support the implementation of TB screening programmes. The operational handbook contains more details about the monitoring, surveillance and evaluation of TB screening interventions (7).

Web Annex I. Diagnostic accuracy of interferon gamma release assays for evaluation of patients with pulmonary TB

Web Annex H. Use of tuberculin skin test or interferon gamma release assays for identifying individuals at greatest risk of progression to active TB

Web Annex G. Mycobacterium tuberculosis antigen-based skin tests: evidence-to-decision table

Web Annex F. Qualitative evidence for the use of Mycobacterium tuberculosis antigen-based skin tests

Web Annex E. Modelling for economic evidence for the use of Mycobacterium tuberculosis antigen-based skin tests

Web Annex D. Cost–effectiveness of Mycobacterium tuberculosis antigen-based skin tests: a systematic review

Web Annex C. GRADE profiles of Mycobacterium tuberculosis antigen-based skin tests

Web Annex B. Safety of Mycobacterium tuberculosis antigen-based skin tests: a systematic review and meta-analysis

Web Annex A. Accuracy of Mycobacterium tuberculosis antigen-based skin tests: a systematic review and meta-analysis